arrow
C

Carrie M. Rosenberger

Genentech
H指数:33
被引数:4,877

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients with Complicated Staphylococcus aureus Bacteremia Receiving Standard-of-Care Antibiotics

一项1b期、随机、双盲、安慰剂对照、多剂量递增研究,旨在探讨DSTA4637S在复杂金黄色葡萄球菌菌血症患者(接受标准护理抗生素治疗)中的安全性、耐受性和药代动力学

2026-09-260
OA
Alternative Splicing Is a Major Factor Shaping Transcriptome Diversity in Mild and Severe Chronic Obstructive Pulmonary Disease

选择性剪接是影响轻度和重度慢性阻塞性肺疾病转录组多样性的主要因素

2024-05-010
PRE
Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis
2023-06-1315
OAAI
Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*
2021-10-1224
OAAI
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model
2017-11-0168
OAAI
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
2017-02-0182
OAAI